END CAPPED NUCLEIC ACID MOLECULES

To disclose, regarding nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, compounds that can be used to make the modified nucleic acids, where the modified nucleic acids have improved expression, lower immunogenicity and improved stability compa...

Full description

Saved in:
Bibliographic Details
Main Authors DAVID BARNES-SEEMAN, JOHN LOUIS DIENER, SARAH WILLIAMS, SCOTT LOUIS COHEN, YUAN JUN, CHRISTIAN GAMPE, JAMES ROACHE, FREDERIC ZECRI, AMY WHITE
Format Patent
LanguageEnglish
Japanese
Published 12.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To disclose, regarding nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, compounds that can be used to make the modified nucleic acids, where the modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.SOLUTION: The present invention provides a compound of formula I or a salt thereof.SELECTED DRAWING: None 【課題】5'末端、3'末端、または5'末端および3'末端に改変を含有する核酸に関し、改変核酸を製造するために使用され得る化合物が開示される。改変核酸は、非改変核酸と比較して、発現の改善、より低い免疫原性、および安定性の改善を有する。【解決手段】式Iの化合物またはその塩。【選択図】なし
AbstractList To disclose, regarding nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, compounds that can be used to make the modified nucleic acids, where the modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.SOLUTION: The present invention provides a compound of formula I or a salt thereof.SELECTED DRAWING: None 【課題】5'末端、3'末端、または5'末端および3'末端に改変を含有する核酸に関し、改変核酸を製造するために使用され得る化合物が開示される。改変核酸は、非改変核酸と比較して、発現の改善、より低い免疫原性、および安定性の改善を有する。【解決手段】式Iの化合物またはその塩。【選択図】なし
Author SCOTT LOUIS COHEN
JOHN LOUIS DIENER
CHRISTIAN GAMPE
DAVID BARNES-SEEMAN
JAMES ROACHE
AMY WHITE
SARAH WILLIAMS
YUAN JUN
FREDERIC ZECRI
Author_xml – fullname: DAVID BARNES-SEEMAN
– fullname: JOHN LOUIS DIENER
– fullname: SARAH WILLIAMS
– fullname: SCOTT LOUIS COHEN
– fullname: YUAN JUN
– fullname: CHRISTIAN GAMPE
– fullname: JAMES ROACHE
– fullname: FREDERIC ZECRI
– fullname: AMY WHITE
BookMark eNrjYmDJy89L5WRQdPVzUXB2DAhwdVHwC3X2cfV0VnB09nRR8PX3cXUO9XEN5mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgZGBoYWxsaWlo7GRCkCAA_8JAU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate エンドキャップされた核酸分子
ExternalDocumentID JP2020183399A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2020183399A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:32:07 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2020183399A3
Notes Application Number: JP20200115238
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201112&DB=EPODOC&CC=JP&NR=2020183399A
ParticipantIDs epo_espacenet_JP2020183399A
PublicationCentury 2000
PublicationDate 20201112
PublicationDateYYYYMMDD 2020-11-12
PublicationDate_xml – month: 11
  year: 2020
  text: 20201112
  day: 12
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies NOVARTIS AG
RelatedCompanies_xml – name: NOVARTIS AG
Score 3.4235685
Snippet To disclose, regarding nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, compounds that can be used to make the modified...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
DERIVATIVES THEREOF
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
Title END CAPPED NUCLEIC ACID MOLECULES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201112&DB=EPODOC&locale=&CC=JP&NR=2020183399A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6JOpYr0rUi_tvpQZEtSttKPoKvsbSRrCyrocBX_fS-10z3tLcnB5QPufndJ7g7gVpg9IecCvRMEe8MxrdwQnukYsixQFeZ9dLNVvHOc9EaZE07daQveVrEwdZ7Q7zo5IkrUHOW9qvX14v8Si9Z_K5d38gWHPh6CiU_1xjtWaGZaOh36jKc0JTohfsj15PGX5tkIx4Mt2EY7uq_EgT0PVVjKYh1TggPY4cjuvTqE1qvowB5ZlV7rwG7cvHhjsxG-5RFcs4RqZMA5o1qSkYiNiTYgY6rFacRIFrGnY7gJ2ISMDJxr9rezWcjX1mWfQBtd_uIUNKcsXGFLS96bqnB5iWaQ8BBJvSJXNoR7Bt0NjM43Uruwr3oqns60LqBdfX4VlwislbyqD-QHqNx2xA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq1KtjyiSW5C82ngIku5uaWIei7bSW9k0CaigxUb8-87GVHvqbdmB2QfMfPPt7uwA3Ai9J9K5QHaCYK9ZupFpwtEtLS1ydIVZH2m2zHeO4t5oYgVTe9qAt1UuTPVP6Hf1OSJa1Bztvaz89eL_EItWbyuXt-kLdn3cD8cuVWt2LNFMN1Q6cBlPaEJUQtyAq_Hjr8wxEY69LdjGGLsvzYE9D2RaymIdU4b7sMNR3Xt5AI1X0YYWWZVea8NuVN94Y7M2vuUhXLGYKsTjnFElnpCQ-UTxiE-VKAkZmYTs6Qiuh2xMRhqONftb2Szga_Myj6GJlD_vgGIVuS3M1EjvdFm4vMAwSDiIpE6eyRjCPoHuBkWnG6WX0BqNo3AW-vFDF_akRObW6cYZNMvPr_wcQbZML6rN-QFl4Xm3
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=END+CAPPED+NUCLEIC+ACID+MOLECULES&rft.inventor=DAVID+BARNES-SEEMAN&rft.inventor=JOHN+LOUIS+DIENER&rft.inventor=SARAH+WILLIAMS&rft.inventor=SCOTT+LOUIS+COHEN&rft.inventor=YUAN+JUN&rft.inventor=CHRISTIAN+GAMPE&rft.inventor=JAMES+ROACHE&rft.inventor=FREDERIC+ZECRI&rft.inventor=AMY+WHITE&rft.date=2020-11-12&rft.externalDBID=A&rft.externalDocID=JP2020183399A